CD24 + cells fuel rapid tumor growth and display high metastatic capacity

Conclusion: CD24 + cells account for heterogeneity in mammary tumors. CD24 expression at early stages of the cancer process is an indication of a highly invasive tumor. However, CD24 is not a suitable therapeutic target; instead we suggest here new potential targets accounting for early differentiated cancer cells tumorigenic capacity.

http://breast-cancer-research.com/content/17/1/78

Source: Breast Cancer Research - June 4, 2015 Category: Cancer & Oncology Authors: Ran RostokerSagi AbelsonInna GenkinSarit Ben-ShmuelRavi SachidanandamEyal ScheinmanKeren Bitton-WormsZila OrrAvishay CaspiMaty TzukermanDerek LeRoith Source Type: research